Smart Blood Glucose Monitors
Smart Blood Glucose Monitors market is segmented by Type and by Application. Players, stakeholder ... Read More
Global Pet Vaccine Market Insights and Forecast to 2031
1 Study Coverage
1.1 Pet Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Pet Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Attenuated Live Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Inactivated Vaccines
1.2.5 Subunit Vaccines
1.2.6 Toxoid Vaccines
1.2.7 DNA Vaccines
1.2.8 Recombinant Vaccines
1.3 Market by Application
1.3.1 Global Pet Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Canine
1.3.3 Avian
1.3.4 Feline
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pet Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Pet Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Pet Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pet Vaccine Sales by Region
2.4.1 Global Pet Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Pet Vaccine by Region (2023-2028)
2.5 Global Pet Vaccine Revenue by Region
2.5.1 Global Pet Vaccine Revenue by Region (2017-2022)
2.5.2 Global Pet Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pet Vaccine Sales by Manufacturers
3.1.1 Global Top Pet Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Pet Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pet Vaccine in 2021
3.2 Global Pet Vaccine Revenue by Manufacturers
3.2.1 Global Pet Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Pet Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pet Vaccine Revenue in 2021
3.3 Global Pet Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pet Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pet Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pet Vaccine Sales by Type
4.1.1 Global Pet Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Pet Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Pet Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Pet Vaccine Revenue by Type
4.2.1 Global Pet Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Pet Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pet Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Pet Vaccine Price by Type
4.3.1 Global Pet Vaccine Price by Type (2017-2022)
4.3.2 Global Pet Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pet Vaccine Sales by Application
5.1.1 Global Pet Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Pet Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Pet Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Pet Vaccine Revenue by Application
5.2.1 Global Pet Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Pet Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pet Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Pet Vaccine Price by Application
5.3.1 Global Pet Vaccine Price by Application (2017-2022)
5.3.2 Global Pet Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pet Vaccine Market Size by Type
6.1.1 North America Pet Vaccine Sales by Type (2017-2028)
6.1.2 North America Pet Vaccine Revenue by Type (2017-2028)
6.2 North America Pet Vaccine Market Size by Application
6.2.1 North America Pet Vaccine Sales by Application (2017-2028)
6.2.2 North America Pet Vaccine Revenue by Application (2017-2028)
6.3 North America Pet Vaccine Market Size by Country
6.3.1 North America Pet Vaccine Sales by Country (2017-2028)
6.3.2 North America Pet Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Pet Vaccine Market Size by Type
7.1.1 Europe Pet Vaccine Sales by Type (2017-2028)
7.1.2 Europe Pet Vaccine Revenue by Type (2017-2028)
7.2 Europe Pet Vaccine Market Size by Application
7.2.1 Europe Pet Vaccine Sales by Application (2017-2028)
7.2.2 Europe Pet Vaccine Revenue by Application (2017-2028)
7.3 Europe Pet Vaccine Market Size by Country
7.3.1 Europe Pet Vaccine Sales by Country (2017-2028)
7.3.2 Europe Pet Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pet Vaccine Market Size by Type
8.1.1 Asia Pacific Pet Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Pet Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Pet Vaccine Market Size by Application
8.2.1 Asia Pacific Pet Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Pet Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Pet Vaccine Market Size by Region
8.3.1 Asia Pacific Pet Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Pet Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Pet Vaccine Market Size by Type
9.1.1 Latin America Pet Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Pet Vaccine Revenue by Type (2017-2028)
9.2 Latin America Pet Vaccine Market Size by Application
9.2.1 Latin America Pet Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Pet Vaccine Revenue by Application (2017-2028)
9.3 Latin America Pet Vaccine Market Size by Country
9.3.1 Latin America Pet Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Pet Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pet Vaccine Market Size by Type
10.1.1 Middle East and Africa Pet Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pet Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Pet Vaccine Market Size by Application
10.2.1 Middle East and Africa Pet Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pet Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Pet Vaccine Market Size by Country
10.3.1 Middle East and Africa Pet Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pet Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer Healthcare
11.1.1 Bayer Healthcare Corporation Information
11.1.2 Bayer Healthcare Overview
11.1.3 Bayer Healthcare Pet Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer Healthcare Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Healthcare Recent Developments
11.2 Vetoquinol S.A
11.2.1 Vetoquinol S.A Corporation Information
11.2.2 Vetoquinol S.A Overview
11.2.3 Vetoquinol S.A Pet Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Vetoquinol S.A Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Vetoquinol S.A Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Pet Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Boehringer Ingelheim Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Ceva
11.4.1 Ceva Corporation Information
11.4.2 Ceva Overview
11.4.3 Ceva Pet Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ceva Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ceva Recent Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Corporation Information
11.5.2 Eli Lilly Overview
11.5.3 Eli Lilly Pet Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Eli Lilly Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eli Lilly Recent Developments
11.6 Heska Co.
11.6.1 Heska Co. Corporation Information
11.6.2 Heska Co. Overview
11.6.3 Heska Co. Pet Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Heska Co. Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Heska Co. Recent Developments
11.7 Merck Animal Health
11.7.1 Merck Animal Health Corporation Information
11.7.2 Merck Animal Health Overview
11.7.3 Merck Animal Health Pet Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Merck Animal Health Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck Animal Health Recent Developments
11.8 Merial (Sanofi)
11.8.1 Merial (Sanofi) Corporation Information
11.8.2 Merial (Sanofi) Overview
11.8.3 Merial (Sanofi) Pet Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Merial (Sanofi) Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merial (Sanofi) Recent Developments
11.9 Virbac
11.9.1 Virbac Corporation Information
11.9.2 Virbac Overview
11.9.3 Virbac Pet Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Virbac Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Virbac Recent Developments
11.10 Zoetis (Pfizer)
11.10.1 Zoetis (Pfizer) Corporation Information
11.10.2 Zoetis (Pfizer) Overview
11.10.3 Zoetis (Pfizer) Pet Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Zoetis (Pfizer) Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Zoetis (Pfizer) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pet Vaccine Industry Chain Analysis
12.2 Pet Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pet Vaccine Production Mode & Process
12.4 Pet Vaccine Sales and Marketing
12.4.1 Pet Vaccine Sales Channels
12.4.2 Pet Vaccine Distributors
12.5 Pet Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pet Vaccine Industry Trends
13.2 Pet Vaccine Market Drivers
13.3 Pet Vaccine Market Challenges
13.4 Pet Vaccine Market Restraints
14 Key Findings in The Global Pet Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Pet Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Attenuated Live Vaccines
Table 3. Major Manufacturers of Conjugate Vaccines
Table 4. Major Manufacturers of Inactivated Vaccines
Table 5. Major Manufacturers of Subunit Vaccines
Table 6. Major Manufacturers of Toxoid Vaccines
Table 7. Major Manufacturers of DNA Vaccines
Table 8. Major Manufacturers of Recombinant Vaccines
Table 9. Global Pet Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Pet Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Pet Vaccine Sales by Region (2017-2022) & (K Doses)
Table 12. Global Pet Vaccine Sales Market Share by Region (2017-2022)
Table 13. Global Pet Vaccine Sales by Region (2023-2028) & (K Doses)
Table 14. Global Pet Vaccine Sales Market Share by Region (2023-2028)
Table 15. Global Pet Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Pet Vaccine Revenue Market Share by Region (2017-2022)
Table 17. Global Pet Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Pet Vaccine Revenue Market Share by Region (2023-2028)
Table 19. Global Pet Vaccine Sales by Manufacturers (2017-2022) & (K Doses)
Table 20. Global Pet Vaccine Sales Share by Manufacturers (2017-2022)
Table 21. Global Pet Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Global Pet Vaccine Revenue Share by Manufacturers (2017-2022)
Table 23. Pet Vaccine Price by Manufacturers (2017-2022) &(USD/Dose)
Table 24. Global Pet Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Pet Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Vaccine as of 2021)
Table 26. Pet Vaccine Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Pet Vaccine Product Offered
Table 28. Date of Manufacturers Enter into Pet Vaccine Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 31. Global Pet Vaccine Sales by Type (2023-2028) & (K Doses)
Table 32. Global Pet Vaccine Sales Share by Type (2017-2022)
Table 33. Global Pet Vaccine Sales Share by Type (2023-2028)
Table 34. Global Pet Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 35. Global Pet Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 36. Global Pet Vaccine Revenue Share by Type (2017-2022)
Table 37. Global Pet Vaccine Revenue Share by Type (2023-2028)
Table 38. Pet Vaccine Price by Type (2017-2022) & (USD/Dose)
Table 39. Global Pet Vaccine Price Forecast by Type (2023-2028) & (USD/Dose)
Table 40. Global Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 41. Global Pet Vaccine Sales by Application (2023-2028) & (K Doses)
Table 42. Global Pet Vaccine Sales Share by Application (2017-2022)
Table 43. Global Pet Vaccine Sales Share by Application (2023-2028)
Table 44. Global Pet Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 45. Global Pet Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 46. Global Pet Vaccine Revenue Share by Application (2017-2022)
Table 47. Global Pet Vaccine Revenue Share by Application (2023-2028)
Table 48. Pet Vaccine Price by Application (2017-2022) & (USD/Dose)
Table 49. Global Pet Vaccine Price Forecast by Application (2023-2028) & (USD/Dose)
Table 50. North America Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 51. North America Pet Vaccine Sales by Type (2023-2028) & (K Doses)
Table 52. North America Pet Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 53. North America Pet Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 54. North America Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 55. North America Pet Vaccine Sales by Application (2023-2028) & (K Doses)
Table 56. North America Pet Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 57. North America Pet Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 58. North America Pet Vaccine Sales by Country (2017-2022) & (K Doses)
Table 59. North America Pet Vaccine Sales by Country (2023-2028) & (K Doses)
Table 60. North America Pet Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 61. North America Pet Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 62. Europe Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 63. Europe Pet Vaccine Sales by Type (2023-2028) & (K Doses)
Table 64. Europe Pet Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 65. Europe Pet Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 66. Europe Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 67. Europe Pet Vaccine Sales by Application (2023-2028) & (K Doses)
Table 68. Europe Pet Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 69. Europe Pet Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 70. Europe Pet Vaccine Sales by Country (2017-2022) & (K Doses)
Table 71. Europe Pet Vaccine Sales by Country (2023-2028) & (K Doses)
Table 72. Europe Pet Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 73. Europe Pet Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 74. Asia Pacific Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 75. Asia Pacific Pet Vaccine Sales by Type (2023-2028) & (K Doses)
Table 76. Asia Pacific Pet Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 77. Asia Pacific Pet Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 78. Asia Pacific Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 79. Asia Pacific Pet Vaccine Sales by Application (2023-2028) & (K Doses)
Table 80. Asia Pacific Pet Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 81. Asia Pacific Pet Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 82. Asia Pacific Pet Vaccine Sales by Region (2017-2022) & (K Doses)
Table 83. Asia Pacific Pet Vaccine Sales by Region (2023-2028) & (K Doses)
Table 84. Asia Pacific Pet Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 85. Asia Pacific Pet Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 86. Latin America Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 87. Latin America Pet Vaccine Sales by Type (2023-2028) & (K Doses)
Table 88. Latin America Pet Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 89. Latin America Pet Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 90. Latin America Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 91. Latin America Pet Vaccine Sales by Application (2023-2028) & (K Doses)
Table 92. Latin America Pet Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 93. Latin America Pet Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 94. Latin America Pet Vaccine Sales by Country (2017-2022) & (K Doses)
Table 95. Latin America Pet Vaccine Sales by Country (2023-2028) & (K Doses)
Table 96. Latin America Pet Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 97. Latin America Pet Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Pet Vaccine Sales by Type (2017-2022) & (K Doses)
Table 99. Middle East and Africa Pet Vaccine Sales by Type (2023-2028) & (K Doses)
Table 100. Middle East and Africa Pet Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Pet Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Pet Vaccine Sales by Application (2017-2022) & (K Doses)
Table 103. Middle East and Africa Pet Vaccine Sales by Application (2023-2028) & (K Doses)
Table 104. Middle East and Africa Pet Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Pet Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 106. Middle East and Africa Pet Vaccine Sales by Country (2017-2022) & (K Doses)
Table 107. Middle East and Africa Pet Vaccine Sales by Country (2023-2028) & (K Doses)
Table 108. Middle East and Africa Pet Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 109. Middle East and Africa Pet Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 110. Bayer Healthcare Corporation Information
Table 111. Bayer Healthcare Description and Major Businesses
Table 112. Bayer Healthcare Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 113. Bayer Healthcare Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Bayer Healthcare Recent Developments
Table 115. Vetoquinol S.A Corporation Information
Table 116. Vetoquinol S.A Description and Major Businesses
Table 117. Vetoquinol S.A Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 118. Vetoquinol S.A Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Vetoquinol S.A Recent Developments
Table 120. Boehringer Ingelheim Corporation Information
Table 121. Boehringer Ingelheim Description and Major Businesses
Table 122. Boehringer Ingelheim Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 123. Boehringer Ingelheim Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Boehringer Ingelheim Recent Developments
Table 125. Ceva Corporation Information
Table 126. Ceva Description and Major Businesses
Table 127. Ceva Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 128. Ceva Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Ceva Recent Developments
Table 130. Eli Lilly Corporation Information
Table 131. Eli Lilly Description and Major Businesses
Table 132. Eli Lilly Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 133. Eli Lilly Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Eli Lilly Recent Developments
Table 135. Heska Co. Corporation Information
Table 136. Heska Co. Description and Major Businesses
Table 137. Heska Co. Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 138. Heska Co. Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Heska Co. Recent Developments
Table 140. Merck Animal Health Corporation Information
Table 141. Merck Animal Health Description and Major Businesses
Table 142. Merck Animal Health Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 143. Merck Animal Health Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Merck Animal Health Recent Developments
Table 145. Merial (Sanofi) Corporation Information
Table 146. Merial (Sanofi) Description and Major Businesses
Table 147. Merial (Sanofi) Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 148. Merial (Sanofi) Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Merial (Sanofi) Recent Developments
Table 150. Virbac Corporation Information
Table 151. Virbac Description and Major Businesses
Table 152. Virbac Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 153. Virbac Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Virbac Recent Developments
Table 155. Zoetis (Pfizer) Corporation Information
Table 156. Zoetis (Pfizer) Description and Major Businesses
Table 157. Zoetis (Pfizer) Pet Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 158. Zoetis (Pfizer) Pet Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Zoetis (Pfizer) Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Pet Vaccine Distributors List
Table 163. Pet Vaccine Customers List
Table 164. Pet Vaccine Market Trends
Table 165. Pet Vaccine Market Drivers
Table 166. Pet Vaccine Market Challenges
Table 167. Pet Vaccine Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Pet Vaccine Product Picture
Figure 3. Global Pet Vaccine Market Share by Type in 2021 & 2028
Figure 3. Attenuated Live Vaccines Product Picture
Figure 4. Conjugate Vaccines Product Picture
Figure 5. Inactivated Vaccines Product Picture
Figure 6. Subunit Vaccines Product Picture
Figure 7. Toxoid Vaccines Product Picture
Figure 8. DNA Vaccines Product Picture
Figure 9. Recombinant Vaccines Product Picture
Figure 10. Global Pet Vaccine Market Share by Application in 2021 & 2028
Figure 11. Canine
Figure 12. Avian
Figure 13. Feline
Figure 14. Pet Vaccine Report Years Considered
Figure 15. Global Pet Vaccine Sales 2017-2028 (K Doses)
Figure 16. Global Pet Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Pet Vaccine Revenue 2017-2028 (US$ Million)
Figure 18. Global Pet Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 19. Global Pet Vaccine Sales Market Share by Region (2017-2022)
Figure 20. Global Pet Vaccine Sales Market Share by Region (2023-2028)
Figure 21. North America Pet Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 22. North America Pet Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Europe Pet Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 24. Europe Pet Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Asia-Pacific Pet Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 26. Asia-Pacific Pet Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Latin America Pet Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 28. Latin America Pet Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Middle East & Africa Pet Vaccine Sales YoY (2017-2028) & (K Doses)
Figure 30. Middle East & Africa Pet Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 31. The Pet Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 32. The Top 5 and 10 Largest Manufacturers of Pet Vaccine in the World: Market Share by Pet Vaccine Revenue in 2021
Figure 33. Global Pet Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 34. Global Pet Vaccine Sales Market Share by Type (2017-2028)
Figure 35. Global Pet Vaccine Revenue Market Share by Type (2017-2028)
Figure 36. Global Pet Vaccine Sales Market Share by Application (2017-2028)
Figure 37. Global Pet Vaccine Revenue Market Share by Application (2017-2028)
Figure 38. North America Pet Vaccine Sales Market Share by Type (2017-2028)
Figure 39. North America Pet Vaccine Revenue Market Share by Type (2017-2028)
Figure 40. North America Pet Vaccine Sales Market Share by Application (2017-2028)
Figure 41. North America Pet Vaccine Revenue Market Share by Application (2017-2028)
Figure 42. North America Pet Vaccine Sales Share by Country (2017-2028)
Figure 43. North America Pet Vaccine Revenue Share by Country (2017-2028)
Figure 44. U.S. Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 45. Canada Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 46. Europe Pet Vaccine Sales Market Share by Type (2017-2028)
Figure 47. Europe Pet Vaccine Revenue Market Share by Type (2017-2028)
Figure 48. Europe Pet Vaccine Sales Market Share by Application (2017-2028)
Figure 49. Europe Pet Vaccine Revenue Market Share by Application (2017-2028)
Figure 50. Europe Pet Vaccine Sales Share by Country (2017-2028)
Figure 51. Europe Pet Vaccine Revenue Share by Country (2017-2028)
Figure 52. Germany Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 53. France Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 54. U.K. Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 55. Italy Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 56. Russia Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 57. Asia Pacific Pet Vaccine Sales Market Share by Type (2017-2028)
Figure 58. Asia Pacific Pet Vaccine Revenue Market Share by Type (2017-2028)
Figure 59. Asia Pacific Pet Vaccine Sales Market Share by Application (2017-2028)
Figure 60. Asia Pacific Pet Vaccine Revenue Market Share by Application (2017-2028)
Figure 61. Asia Pacific Pet Vaccine Sales Share by Region (2017-2028)
Figure 62. Asia Pacific Pet Vaccine Revenue Share by Region (2017-2028)
Figure 63. China Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 64. Japan Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 65. South Korea Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 66. India Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 67. Australia Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 68. Taiwan Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 69. Indonesia Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 70. Thailand Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 71. Malaysia Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 72. Philippines Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 73. Latin America Pet Vaccine Sales Market Share by Type (2017-2028)
Figure 74. Latin America Pet Vaccine Revenue Market Share by Type (2017-2028)
Figure 75. Latin America Pet Vaccine Sales Market Share by Application (2017-2028)
Figure 76. Latin America Pet Vaccine Revenue Market Share by Application (2017-2028)
Figure 77. Latin America Pet Vaccine Sales Share by Country (2017-2028)
Figure 78. Latin America Pet Vaccine Revenue Share by Country (2017-2028)
Figure 79. Mexico Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 80. Brazil Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 81. Argentina Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 82. Middle East and Africa Pet Vaccine Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Pet Vaccine Revenue Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Pet Vaccine Sales Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Pet Vaccine Revenue Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Pet Vaccine Sales Share by Country (2017-2028)
Figure 87. Middle East and Africa Pet Vaccine Revenue Share by Country (2017-2028)
Figure 88. Turkey Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 89. Saudi Arabia Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 90. U.A.E Pet Vaccine Revenue (2017-2028) & (US$ Million)
Figure 91. Pet Vaccine Value Chain
Figure 92. Pet Vaccine Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer Healthcare Vetoquinol S.A Boehringer Ingelheim Ceva Eli Lilly Heska Co. Merck Animal Health Merial (Sanofi) Virbac Zoetis (Pfizer)